Deepti Sreepathi

Deepti Sreepathi brings 18 years of scientific research experience and 10 years in the biopharmaceutical industry to her work in clinical development and operations. Her background in computational sciences and scientific leadership stems from her educational studies, and her expertise ranges from clinical research programs in rare disease, to MedTech and AI applications in enhancing the understanding of disease pathology and improving patient outcomes. Her therapeutic expertise spans oncology, ophthalmology, neurology, immunology, and gene therapy. She has experience working across smaller biotechs and larger structured companies on projects ranging from $100,000 to $40 million, with multi-regional involvement in Asia, South America, Europe, and North America. Her professional affiliations include the Association of Clinical Research Professionals, the IEEE Computational Intelligence Society, the American Society of Microbiology, and she has served on global biotech medical and clinical review committees. Notable achievements include contributing to therapies that reached the market, enabling patients to access treatments sooner.